CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase Ib/IIa Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02583542
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:48.840974+00:00
- Published At
- 2020-02-25T00:00:00+00:00
- Record Updated At
- 2020-02-25
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Triple-Negative Breast Cancer", "Squamous Cell Lung Cancer", "Non-squamous Cell Lung Cancer With KRAS Mutations", "Non-squamous Cell Lung Cancer With Wild-type KRAS"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-02-25"- protocolSection.identificationModule.nctId
"NCT02583542"- protocolSection.identificationModule.officialTitle
"A Phase Ib/IIa Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.